当前位置:首页 - 行情中心 - 海辰药业(300584) - 财务分析 - 现金流量表

海辰药业

(300584)

  

流通市值:42.95亿  总市值:62.77亿
流通股本:8211.07万   总股本:1.20亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金454,087,572.94313,542,042.48151,327,782.5500,092,543.2
  收到的税费返还17,883,14411,216,039.6911,216,039.6929,488,306.58
  收到其他与经营活动有关的现金5,756,342.61,648,650.961,251,757.442,348,713.48
  经营活动现金流入小计477,727,059.54326,406,733.13163,795,579.63531,929,563.26
  购买商品、接受劳务支付的现金29,274,321.7318,349,449.7510,117,367.4250,615,347.36
  支付给职工以及为职工支付的现金56,591,262.337,288,297.4321,127,895.8970,723,431.8
  支付的各项税费70,015,508.7448,179,255.4223,395,327.1176,024,694.05
  支付其他与经营活动有关的现金263,359,297.98156,951,984.4265,995,687.82274,605,948.23
  经营活动现金流出小计419,240,390.75260,768,987.02120,636,278.24471,969,421.44
  经营活动产生的现金流量净额58,486,668.7965,637,746.1143,159,301.3959,960,141.82
二、投资活动产生的现金流量:
  收回投资收到的现金1,000,344.951,000,344.951,000,344.952,003,517.81
  处置固定资产、无形资产和其他长期资产收回的现金净额59,076,534.1129,180,406.065,464.55,392
  投资活动现金流入小计60,076,879.0630,180,751.011,005,809.452,008,909.81
  购建固定资产、无形资产和其他长期资产支付的现金57,109,231.5239,258,022.7127,151,835.7577,936,524.65
  投资支付的现金9,100,0009,100,0009,100,0002,000,000
  投资活动现金流出小计66,209,231.5248,358,022.7136,251,835.7579,936,524.65
  投资活动产生的现金流量净额-6,132,352.46-18,177,271.7-35,246,026.3-77,927,614.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金15,000,000--16,500,000
  其中:子公司吸收少数股东投资收到的现金15,000,000--16,500,000
  取得借款收到的现金169,500,000115,500,00065,500,000273,500,000
  收到其他与筹资活动有关的现金18,600,00018,600,00010,000,00074,336,273.14
  筹资活动现金流入小计203,100,000134,100,00075,500,000364,336,273.14
  偿还债务支付的现金161,300,000101,200,00060,100,000260,100,000
  分配股利、利润或偿付利息支付的现金17,699,582.3415,820,205.411,927,039.5913,851,109.99
  支付其他与筹资活动有关的现金46,089,174.1539,089,174.1515,910,915.2673,472,372.22
  筹资活动现金流出小计225,088,756.49156,109,379.5677,937,954.85347,423,482.21
  筹资活动产生的现金流量净额-21,988,756.49-22,009,379.56-2,437,954.8516,912,790.93
四、汇率变动对现金及现金等价物的影响19,877.4821,764.186,711.27-8,688.23
五、现金及现金等价物净增加额30,385,437.3225,472,859.035,482,031.51-1,063,370.32
  加:期初现金及现金等价物余额45,758,717.8345,758,717.8345,758,717.8346,822,088.15
  期末现金及现金等价物余额76,144,155.1571,231,576.8651,240,749.3445,758,717.83
补充资料:
  净利润-28,878,476.75-40,162,971.25
  资产减值准备-8,635,020.7-9,049,612.26
  固定资产和投资性房地产折旧-13,526,764.15-27,767,967.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,526,764.15-27,767,967.59
  无形资产摊销-14,879,581.42-25,161,216.66
  处置固定资产、无形资产和其他长期资产的损失--482,279.37--
  固定资产报废损失-332,529.09-291,206.3
  财务费用-3,447,312.21-8,871,901.68
  投资损失-1,225,456.46--3,318.69
  递延所得税--5,894,949.34--5,790,680.08
  其中:递延所得税资产减少--1,662,683.22--3,651,076.82
    递延所得税负债增加--4,232,266.12--2,139,603.26
  存货的减少--1,685,688.6--13,441,920.84
  经营性应收项目的减少--4,122,420.6--49,871,785.88
  经营性应付项目的增加-6,669,810.12-17,762,971.57
  现金的期末余额-71,231,576.86-45,758,717.83
  减:现金的期初余额-45,758,717.83-46,822,088.15
  现金及现金等价物的净增加额-25,472,859.03--1,063,370.32
公告日期2025-10-232025-08-232025-04-212025-04-21
审计意见(境内)标准无保留意见
TOP↑